In Naples, today December 5th and tomorrow, the important scientific meeting "Hot Topics on Sarcomas: Precision, Proximity, ...
Experts discuss the complexities of observing desmoid tumors, weighing the benefits of active surveillance against the need ...
November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...
Truist analyst Karina Rabayeva initiated coverage of Immunome (IMNM) with a Buy rating and $36 price target The company’s lead asset, ...
Profound would also like to congratulate Satoru Takahashi, MD, PhD, of Takatsuki General Hospital in Japan, for receiving a Certificate of Merit award from RSNA for his presentation titled “TULSA for ...